Key regions: France, Australia, India, South Korea, Germany
The Other OTC Pharmaceuticals (Pharmacies) market in Northern Europe is experiencing significant growth and development. Customer preferences in the region are playing a crucial role in shaping the market. Consumers in Northern Europe have a strong preference for self-care and are increasingly turning to over-the-counter (OTC) pharmaceuticals for minor ailments and health concerns. This shift in consumer behavior is driven by several factors, including convenience, cost-effectiveness, and a desire for greater control over their own health. As a result, the demand for OTC pharmaceuticals in pharmacies has been steadily increasing. Trends in the market indicate a growing focus on preventive healthcare and wellness. Consumers in Northern Europe are becoming more proactive in managing their health and are seeking products that can help them maintain a healthy lifestyle. This has led to an increased demand for vitamins, supplements, and other OTC products that promote general well-being. Additionally, there is a rising interest in natural and herbal remedies, as consumers are becoming more conscious of the potential side effects of traditional pharmaceuticals. Local special circumstances also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in Northern Europe. The region has a well-established healthcare system that provides easy access to pharmacies and promotes the use of OTC medications. Additionally, the high level of education and awareness among the population further drives the demand for self-care products. Pharmacies in Northern Europe are also known for their knowledgeable staff who can provide advice and guidance on OTC products, which enhances the overall customer experience and encourages repeat purchases. Underlying macroeconomic factors also play a role in the growth of the market. Northern Europe has a stable and prosperous economy, which translates into higher disposable incomes and increased spending power. This enables consumers to afford OTC pharmaceuticals and encourages them to invest in their health. Furthermore, the region's aging population is another contributing factor, as older individuals often require OTC medications for chronic conditions and age-related health issues. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Northern Europe is thriving due to customer preferences for self-care, the growing focus on preventive healthcare, local special circumstances such as easy access to pharmacies and knowledgeable staff, and underlying macroeconomic factors such as a stable economy and an aging population. This market is expected to continue its upward trajectory as consumers prioritize their health and well-being.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
